Prostate Cancer
News and reporting on prostate cancer.
PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection
In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed.
MDxHealth H1 2021 Revenues Up 9 Percent As Testing Volumes Rebound
The firm saw volume growth of 4 percent for its ConfirmMDx prostate cancer test and 9 percent for its SelectMDx test.
PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps
In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.
Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib
The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib.
Mar 17, 2021
Mar 3, 2021
MDxHealth 2020 Revenues Up 57 Percent
Feb 2, 2021
Bio-Techne Fiscal Q2 Revenues Rise 21 Percent
Nov 23, 2020